Department of Nephrology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Department of Health Promotion Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
CEN Case Rep. 2023 Feb;12(1):110-115. doi: 10.1007/s13730-022-00729-8. Epub 2022 Aug 26.
An 88-year-old male patient on maintenance hemodialysis (HD) therapy experienced gradual losses in appetite and liveliness during the course of 1 month. Physical examinations revealed no abnormalities. However, blood testing indicated non-thyroidal illness syndrome (NTIS) typically observed in patients with severe illness, with serum levels of thyroid stimulating hormone, free triiodothyronine, and free thyroxine of 0.17 μIU/mL, < 1.0 pg/mL, and 0.23 ng/dL, respectively. Brain magnetic resonance imaging to exclude the possibility of central hypothyroidism unexpectedly displayed slight abnormalities inside of the thalami that were characteristic of Wernicke's encephalopathy. Additional examination disclosed low serum thiamine of 20 ng/mL. Thiamine injections of 100 mg at every HD treatment rapidly restored his appetite, liveliness, and NTIS findings. HD patients are at a particularly high risk of thiamine deficiency (TD) and associated severe symptoms due to losses of thiamine during HD sessions. However, its non-specific initial symptoms, including decreases in appetite and liveliness, as well as undetectability in routine blood tests complicate early detection, resulting in underdiagnosis and more severe outcomes. In the present case, TD manifested only as non-specific symptoms and was ultimately revealed by the presence of NTIS, which was resolved with thiamine supplementation. Thus, NTIS might assist in the early detection of TD as an initial sign in HD patients.
一位 88 岁男性维持性血液透析(HD)患者在 1 个月的病程中逐渐出现食欲减退和精神不振。体格检查无异常。然而,血液检测提示存在非甲状腺疾病综合征(NTIS),这是重症患者常见的表现,血清促甲状腺激素、游离三碘甲状腺原氨酸和游离甲状腺素水平分别为 0.17μIU/mL、<1.0pg/mL 和 0.23ng/dL。为排除中枢性甲状腺功能减退症,对患者行脑磁共振成像检查,结果显示双侧丘脑有轻微异常,这是韦尼克脑病的特征性表现。进一步检查发现血清硫胺素水平较低,为 20ng/mL。每次 HD 治疗时给予 100mg 硫胺素注射,迅速恢复了患者的食欲、精神状态和 NTIS 表现。HD 患者由于 HD 治疗过程中丢失硫胺素,存在发生硫胺素缺乏(TD)和相关严重症状的极高风险。然而,其非特异性的初始症状,包括食欲减退和精神不振,以及常规血液检查无法检测到,使得早期检测变得复杂,导致漏诊和更严重的后果。在本病例中,TD 仅表现为非特异性症状,最终通过 NTIS 得以揭示,补充硫胺素后 NTIS 得到缓解。因此,NTIS 可能有助于作为 HD 患者的初始迹象,早期发现 TD。